{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:30:29Z","timestamp":1768469429561,"version":"3.49.0"},"reference-count":24,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:p>Two quite different disc contents are used for antimicrobial susceptibility testing of two fluoroquinolone drugs, flumequine and enrofloxacin, in the disc diffusion test, 30 and 5\u00a0\u00b5g, respectively. Using the SRA method, single\u2010strain regression analysis, we studied the impact of disc content when testing two relevant bacterial species, <jats:italic>Aeromonas sobria<\/jats:italic> and <jats:italic>Vibrio anguillarum<\/jats:italic>. There were no major differences between the antimicrobial regression lines for the two species. Wild\u2010type strains produced acceptable zones of inhibition over a wide range of disc contents. The flumequine 30\u00a0\u00b5g disc should be lowered in its drug content. No rational reasons for choosing so different disc contents for the two antimicrobials were apparent. At present, the choice of disc content for new antimicrobials are outside the realm of clinical microbiologists. It is recommended that reference authorities, such as EUCAST, CLSI and USCAST, are consulted for the choice of disc contents in the future.<\/jats:p>","DOI":"10.1111\/apm.12972","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T08:28:29Z","timestamp":1561364909000},"page":"570-576","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single\u2010strain regression analysis evaluating disc potencies of flumequine and enrofloxacin for testing <i>Aeromonas sobria<\/i> and <i>Vibrio anguillarum<\/i>"],"prefix":"10.1111","volume":"127","author":[{"given":"G\u00f6ran","family":"Kronvall","sequence":"first","affiliation":[{"name":"Division of Clinical Microbiology, Department of Laboratory Medicine Karolinska Institute Stockholm Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Baron","sequence":"additional","affiliation":[{"name":"Mycoplasmology\u2010Bacteriology and Antimicrobial Resistance Unit, Ploufragan\u2010Plouzan\u00e9\u2010Niort Laboratory French Agency for Food, Environmental and Occupational Health and Safety (ANSES) Ploufragan France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeline","family":"Larvor","sequence":"additional","affiliation":[{"name":"Mycoplasmology\u2010Bacteriology and Antimicrobial Resistance Unit, Ploufragan\u2010Plouzan\u00e9\u2010Niort Laboratory French Agency for Food, Environmental and Occupational Health and Safety (ANSES) Ploufragan France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casandra","family":"Rudas\u2013Villarreal","sequence":"additional","affiliation":[{"name":"Mast Group Ltd. Bootle Merseyside UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Hobson","sequence":"additional","affiliation":[{"name":"Mast Group Ltd. Bootle Merseyside UK"},{"name":"School of Pharmacy and Biomolecular Sciences Liverpool John Moores University Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Microbiology National University of Ireland Galway Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,7,19]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"766","volume-title":"Antibiotics in Laboratory Medicine","author":"Shungu DL","year":"1996"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/45.4_ts.493"},{"issue":"11","key":"e_1_2_8_4_1","first-page":"23","article-title":"A paper disk method for determination of bacterial sensitivity to chemotherapeutic and antibiotic agents","volume":"6","author":"Ericsson H","year":"1954","journal-title":"Scand J Clin Lab Invest"},{"key":"e_1_2_8_5_1","first-page":"138","article-title":"Improving the accuracy of disc diffusion antibiotic susceptibility testing using species\u2010related interpretive zone breakpoints","volume":"16","author":"Kronvall G","year":"1998","journal-title":"Indian Journal of Medical Microbiology"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365549950164463"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2000.00031.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2002.1101002.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/jcm.16.5.784-793.1982","article-title":"Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter breakpoints in quality control of disk diffusion antibiotic susceptibility testing","volume":"16","author":"Kronvall G","year":"1982","journal-title":"J Clin Microbiol"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2761.2011.01279.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.13.4.769-777.1981"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.6281"},{"key":"e_1_2_8_13_1","first-page":"510","article-title":"Clinical presentations, prognostic factors, and mortality in patients with Aeromonas sobria complex bacteremia in a teaching hospital: a 5\u2010year experience","volume":"42","author":"Wang JH","year":"2009","journal-title":"J Microbiol Immunol Infect"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2761.2005.00608.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00662030"},{"key":"e_1_2_8_16_1","unstructured":"CLSI CaLSI.Performance Standards for Antimicrobial Disk Susceptibility Tests.13th ed. CLSI Standard M02. Vet 03\/A. Clinical and Laboratory Standards Institute;2018."},{"key":"e_1_2_8_17_1","unstructured":"CLSI CaLSI.Methods for Antimicrobial Disk Susceptibility testing of Bacteria Isolated from Aquatic Animals; Approved Guideline. CLSI documents M42\u2010A. ISBN 1\u201056238\u2010611\u20105. Clinical and Laboratory Standards Institute;2006."},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1991.tb05153.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2000.00135.x"},{"key":"e_1_2_8_20_1","first-page":"1","article-title":"Antibiotic sensitivity testing. Report of an international collaborative study","volume":"217","author":"Ericsson HM","year":"1971","journal-title":"Acta Path Microbiol Scand Sect B"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00503"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1470-9465.2004.00865.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/124.Supplement_1.S207"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1991.tb01275.x"},{"key":"e_1_2_8_25_1","first-page":"13","article-title":"Single\u2010strain regression analysis for quality control of cephalothin\u2010susceptibility testing and determination of interpretive breakpoints","volume":"92","author":"Kronvall G","year":"1984","journal-title":"Acta Path Microbiol Immunol Scand Sect B"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapm.12972","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apm.12972","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/apm.12972","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apm.12972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T23:19:27Z","timestamp":1694301567000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apm.12972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,19]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1111\/apm.12972"],"URL":"https:\/\/doi.org\/10.1111\/apm.12972","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,19]]},"assertion":[{"value":"2019-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}